Several ligands were found to sensitize TRPV1 after the prolonged exposure (Fig. 1e) and cancer chemotherapeutic agents were among the top such TRPV1 sensitizing agents (Supplementary Table 1). The gene discussed is TRPV1; the disease is cancer.